Living donor liver transplantation in patients with hepatitis C

Area of Science:

• Hepatology
• Transplantation Immunology
• Virology

Background:

• Hepatitis C virus (HCV) is a leading cause of liver disease and a primary indication for liver transplantation.
• Living donor liver transplantation (LDLT) is an established procedure for end-stage liver disease.
• Preliminary data suggests potential differences in HCV recurrence post-LDLT compared to deceased donor liver transplantation.

Purpose of the Study:

• To review and discuss the current evidence regarding HCV recurrence in LDLT recipients.
• To explore potential mechanisms contributing to the severity of HCV in LDLT recipients.
• To evaluate the impact of recurrent HCV on patient and graft survival after LDLT.

Main Methods:

• Literature review of studies investigating HCV recurrence after LDLT.
• Analysis of preliminary data on HCV severity and outcomes in LDLT recipients.
• Discussion of hypothetical mechanisms for observed differences in HCV pathogenesis.

Main Results:

• HCV is the most common reason for LDLT.
• Early evidence indicates potentially earlier and more severe HCV recurrence in LDLT recipients.
• Data on the definitive impact of recurrent HCV on survival outcomes in LDLT recipients remains inconclusive.

Conclusions:

• LDLT is a feasible treatment option for carefully selected patients with HCV.
• Further research is essential to clarify the long-term outcomes of HCV recurrence in LDLT.
• Understanding the mechanisms of HCV severity in LDLT is crucial for improving patient management.